Literature DB >> 16537366

Nitric oxide and cisplatin resistance: NO easy answers.

John J Turchi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16537366      PMCID： PMC1450170          DOI： 10.1073/pnas.0601001103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

1.  S-nitrosylation regulates apoptosis.

Authors:  G Melino; F Bernassola; R A Knight; M T Corasaniti; G Nistico; A Finazzi-Agro
Journal:  Nature       Date:  1997-07-31       Impact factor: 49.962

Review 2.  Glutathione and drug resistance.

Authors:  C P Schröder; A K Godwin; P J O'Dwyer; K D Tew; T C Hamilton; R F Ozols
Journal:  Cancer Invest       Date:  1996       Impact factor: 2.176

Review 3.  Platinums: extending their therapeutic spectrum.

Authors:  F M Muggia; T Fojo
Journal:  J Chemother       Date:  2004-11       Impact factor: 1.714

4.  In vitro metabolism of nitric oxide-donating aspirin: the effect of positional isomerism.

Authors:  Jianjun Gao; Khosrow Kashfi; Basil Rigas
Journal:  J Pharmacol Exp Ther       Date:  2004-11-04       Impact factor: 4.030

5.  Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin.

Authors:  D A Wink; J A Cook; D Christodoulou; M C Krishna; R Pacelli; S Kim; W DeGraff; J Gamson; Y Vodovotz; A Russo; J B Mitchell
Journal:  Nitric Oxide       Date:  1997-02       Impact factor: 4.427

6.  Nitric oxide inhibits DNA-adduct excision in nucleotide excision repair.

Authors:  Yuan-Hung Chien; Da-Tian Bau; Kun-Yan Jan
Journal:  Free Radic Biol Med       Date:  2004-04-15       Impact factor: 7.376

Review 7.  Nitric oxide as a unique signaling molecule in the vascular system: a historical overview.

Authors:  L J Ignarro
Journal:  J Physiol Pharmacol       Date:  2002-12       Impact factor: 3.011

8.  In vitro metabolism of a nitroderivative of acetylsalicylic acid (NCX4016) by rat liver: LC and LC-MS studies.

Authors:  Marina Carini; Giancarlo Aldini; Marica Orioli; Roberto Maffei Facino
Journal:  J Pharm Biomed Anal       Date:  2002-08-01       Impact factor: 3.935

9.  Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation.

Authors:  Jie Liu; Chengxiu Li; Wei Qu; Elaine Leslie; Challice L Bonifant; Gregory S Buzard; Joseph E Saavedra; Larry K Keefer; Michael P Waalkes
Journal:  Mol Cancer Ther       Date:  2004-06       Impact factor: 6.261

10.  NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?

Authors:  Raymond K Yeh; Jie Chen; Jennie L Williams; Mehdi Baluch; Thomas R Hundley; Raphael E Rosenbaum; Srinivas Kalala; Frank Traganos; Francesca Benardini; Piero del Soldato; Khosrow Kashfi; Basil Rigas
Journal:  Biochem Pharmacol       Date:  2004-06-15       Impact factor: 5.858
View more
  8 in total

Review 1.  Combination of nitric oxide and drug delivery systems: tools for overcoming drug resistance in chemotherapy.

Authors:  Jihoon Kim; Bryant C Yung; Won Jong Kim; Xiaoyuan Chen
Journal:  J Control Release       Date:  2016-12-26       Impact factor: 9.776

2.  Bim protein degradation contributes to cisplatin resistance.

Authors:  Juan Wang; Jun-Ying Zhou; Gen Sheng Wu
Journal:  J Biol Chem       Date:  2011-05-11       Impact factor: 5.157

3.  Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cells.

Authors:  Dong-Jun Peng; Juan Wang; Jun-Ying Zhou; Gen Sheng Wu
Journal:  Biochem Biophys Res Commun       Date:  2010-03-07       Impact factor: 3.575

4.  Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53.

Authors:  J Kitagaki; Y Yang; J E Saavedra; N H Colburn; L K Keefer; A O Perantoni
Journal:  Oncogene       Date:  2008-11-03       Impact factor: 9.867

5.  NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts.

Authors:  Karuppaiyah Selvendiran; Anna Bratasz; Liyue Tong; Louis J Ignarro; Periannan Kuppusamy
Journal:  Cell Cycle       Date:  2007-09-28       Impact factor: 4.534

6.  The Role of Magnesium Supplementation in Cisplatin-induced Nephrotoxicity in a Rat Model: No Nephroprotectant Effect.

Authors:  Farzaneh Ashrafi; Sara Haghshenas; Mehdi Nematbakhsh; Hamid Nasri; Ardeshir Talebi; Fatemeh Eshraghi-Jazi; Zahra Pezeshki; Tahereh Safari
Journal:  Int J Prev Med       Date:  2012-09

Review 7.  Glutathione S-conjugates as prodrugs to target drug-resistant tumors.

Authors:  Emma E Ramsay; Pierre J Dilda
Journal:  Front Pharmacol       Date:  2014-08-11       Impact factor: 5.810

8.  Solid-phase synthesis provides a modular, lysine-based platform for fluorescent discrimination of nitroxyl and biological thiols.

Authors:  Andrei Loas; Robert J Radford; Alexandria Deliz Liang; Stephen J Lippard
Journal:  Chem Sci       Date:  2015-05-19       Impact factor: 9.825
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.